Increasing the power of identifying gene x gene interactions in genome-wide association studies.

Genetic Epidemiology
Charles Kooperberg, Michael Leblanc

Abstract

In this paper we investigate the power to identify gene x gene interactions in genome-wide association studies. In our analysis we focus on two-stage analyses: analyses in which we only test for interactions between single nucleotide polymorphisms that show some marginal effect. We give two algorithms to compute significance levels for such an analyses. One involves a Bonferoni correction on the number of interactions that are actually tested, and one is a resampling procedure similar to the one proposed by [Lin (2006) Am. J. Hum. Genet. 78:505-509]. We also give an algorithm to carry out approximate power calculations for studies that plan to use a two-stage analysis. We find that for most plausible interaction effects a two-stage analysis can dramatically increase the power to identify interactions compared to a single-stage analysis based on simulation studies using known genetic models and data from existing genome-wide association studies.

References

Nov 16, 2004·Genetic Epidemiology·Duncan ThomasMulugeta Gebregziabher
Mar 29, 2005·Nature Genetics·Jonathan MarchiniLon R Cardon
Jan 13, 2006·American Journal of Human Genetics·D Y Lin
Apr 6, 2006·BMC Medical Genetics·Stuart Macgregor, Imtiaz A Khan
Sep 28, 2006·PLoS Genetics·David M EvansLon R Cardon
Dec 23, 2006·American Journal of Human Genetics·Nilanjan ChatterjeeSholom Wacholder
Feb 7, 2007·Human Heredity·Teri A Manolio, Francis S Collins
May 29, 2007·Nature·Douglas F EastonBruce A J Ponder
Jun 6, 2007·Genetic Epidemiology·Andrew D SkolMichael Boehnke
Jun 8, 2007·Nature·UNKNOWN Wellcome Trust Case Control Consortium

❮ Previous
Next ❯

Citations

Sep 3, 2011·Current Diabetes Reports·Paul W Franks
Feb 16, 2012·European Journal of Human Genetics : EJHG·Wen-Hua WeiChris S Haley
Jun 8, 2007·Nature·UNKNOWN Wellcome Trust Case Control Consortium
Mar 10, 2010·Nature Reviews. Genetics·Duncan Thomas
Dec 27, 2011·American Journal of Epidemiology·Duncan C ThomasW James Gauderman
Dec 27, 2011·American Journal of Epidemiology·Bhramar MukherjeeNilanjan Chatterjee
Jul 10, 2012·American Journal of Epidemiology·James Y DaiCharles Kooperberg
Mar 29, 2011·Briefings in Bioinformatics·Kristel Van Steen
Feb 2, 2012·Mutagenesis·Richard S Houlston, UNKNOWN members of COGENT
Aug 24, 2010·Annals of Human Genetics·Tyler J VanderWeele, Nan M Laird
Nov 5, 2008·Annual Review of Public Health·Stephanie J London, Isabelle Romieu
Sep 22, 2011·Human Heredity·Wei PanXiaotong Shen
Dec 19, 2009·BMC Proceedings·Jia LiMariza de Andrade
Apr 20, 2014·PLoS Genetics·Jane C FigueiredoUNKNOWN GECCO
Aug 6, 2010·PloS One·Francesco Lescai, Claudio Franceschi
Jan 10, 2013·PloS One·Shuo JiaoUlrike Peters
Sep 29, 2011·Yi chuan = Hereditas·Fang-Ge LiHui Li
Aug 12, 2014·Human Genetics·Wolfgang SadeeGrzegorz A Rempala
Jul 5, 2012·Human Genetics·Hugues AschardKristel Van Steen
Dec 1, 2012·The Journal of Allergy and Clinical Immunology·Francine Kauffmann, Florence Demenais
Aug 6, 2011·Parkinsonism & Related Disorders·Joanna M BiernackaDemetrius M Maraganore
Dec 6, 2008·Genetic Epidemiology·Minsun Song, Dan L Nicolae
Jul 23, 2013·Genetic Epidemiology·W James GaudermanJuan Pablo Lewinger
Feb 11, 2011·Genetic Epidemiology·Cassandra E MurcrayW James Gauderman
Jul 12, 2012·Genetic Epidemiology·Indika RajapakseCharles Kooperberg
Jun 21, 2012·Genetic Epidemiology·Li HsuCharles Kooperberg
Jul 3, 2013·Journal of Child Psychology and Psychiatry, and Allied Disciplines·Stacey J Winham, Joanna M Biernacka

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.